Issue navigation
Volume 4, Issue 1, January 2018
Editorial
Cardiovascular pharmacotherapy
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 4, Issue 1, January 2018, Page 1, https://doi.org/10.1093/ehjcvp/pvx036
Invited Editorials
Changing paradigms in oral anticoagulation during cardioversion in Europe
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 4, Issue 1, January 2018, Pages 2–3, https://doi.org/10.1093/ehjcvp/pvx025
Market licensing of type 2 diabetes medicinal products based on patient-relevant hard outcomes: is there hope?
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 4, Issue 1, January 2018, Pages 4–5, https://doi.org/10.1093/ehjcvp/pvx026
Correspondence
Worldwide reporting of fatal outcomes after ticagrelor to the US Food and Drug Administration
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 4, Issue 1, January 2018, Pages 6–9, https://doi.org/10.1093/ehjcvp/pvx024
Invited Editorial
Importance of post-approval real-word evidence
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 4, Issue 1, January 2018, Pages 10–11, https://doi.org/10.1093/ehjcvp/pvx035
Correspondence
Is ticagrelor safe in octogenarian patients with non-ST elevation acute coronary syndromes?
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 4, Issue 1, January 2018, Pages 12–14, https://doi.org/10.1093/ehjcvp/pvx034
Original Article
Prevention and epidemiology
Modelling the cost-effectiveness of PCSK9 inhibitors vs. ezetimibe through LDL-C reductions in a Norwegian setting
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 4, Issue 1, January 2018, Pages 15–22, https://doi.org/10.1093/ehjcvp/pvx010
Editorial
Cost-effectiveness with PCSK9 inhibitors: a matter of costs
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 4, Issue 1, January 2018, Pages 23–24, https://doi.org/10.1093/ehjcvp/pvx030
Original Articles
Coronary artery disease
Coronary artery disease severity and long-term cardiovascular risk in patients with myocardial infarction: a Danish nationwide register-based cohort study
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 4, Issue 1, January 2018, Pages 25–35, https://doi.org/10.1093/ehjcvp/pvx009
Acute Coronary Syndromes
Antithrombotic therapy after myocardial infarction in patients with atrial fibrillation undergoing percutaneous coronary intervention
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 4, Issue 1, January 2018, Pages 36–45, https://doi.org/10.1093/ehjcvp/pvx033
Reviews
Interleukin-1 blockade for the treatment of pericarditis
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 4, Issue 1, January 2018, Pages 46–53, https://doi.org/10.1093/ehjcvp/pvx018
Heart failure/cardiomyopathy
Loop diuretics for chronic heart failure: a foe in disguise of a friend?
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 4, Issue 1, January 2018, Pages 54–63, https://doi.org/10.1093/ehjcvp/pvx020
